# Efficacy Study in Patients With Acne Vulgaris.

> **NCT02935036** · PHASE2 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 294 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** ADPS topical product
- **DRUG:** Placebo Control

## Key facts

- **NCT ID:** NCT02935036
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-03
- **Primary completion:** 2017-01-24
- **Final completion:** 2017-03-21
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2018-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02935036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02935036, "Efficacy Study in Patients With Acne Vulgaris.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02935036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*